Export Coffee Talk | Japan Biotech Panel | Market Entry Insights
October 31 @ 10:00 am - 12:00 pm
Free
Join us in-person or virtually Thursday, October 31, from 10:00 am to 12:00 pm ET for a special hybrid Export Coffee Talk in RTP. The panel will provide drug development and market entry insights focused on Japan’s biotechnology industry. The information would benefit biotech companies that aim to enter Japanese and Asian markets and contract research organizations (CROs) supporting those biotech companies.
Panelists:
- Hiroshi Yamabe, Founder and CEO, Swanielle, Inc. – Tokyo, Japan-based proposal and business execution consultant for the healthcare industry will brief on “drug loss” in Japan and discuss policy change implications.
- Paula Brown Stafford, CEO of Allucent – Leader of a North Carolina-headquartered CRO that supports small and mid-sized biotech companies will provide insights on business with Japanese pharmaceutical companies.
- Tomoko Maeda-Chubachi, President, TMC Clinicial Development Consulting, Inc. – Advisor and consultant for pharmaceutical and biotech companies, will add her expertise and provide some information about Japan’s Pharmaceuticals and Medical Device Agency (PMDA).
- David Robinson, the program moderator, brings decades of Japan-related business experience to the conversation. He is the Honorary Consul for Japan in North Carolina, Chairman of the Board of the Japan-America Society of North Carolina, and an International Trade and Investment and International Corporate Compliance Attorney with the national law firm, Maynard Nexsen.